Category: Latest News
-
60 Degrees Pharmaceuticals reports three cures in babesiosis expanded access trial
60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP) announced that all three patients enrolled in its expanded access study for relapsing babesiosis were successfully cured after completing a treatment regimen based on tafenoquine, according to a company press release. Despite the positive clinical update, the company’s stock has struggled over the past year. Shares recently traded at about…
-
Nebius shares jump after NVIDIA announces $2 billion cloud partnership
Nebius Group N.V. (NASDAQ:NBIS) shares climbed about 10% on Wednesday morning after NVIDIA (NASDAQ:NVDA) revealed plans to invest $2 billion in the company as part of a strategic collaboration to expand hyperscale cloud infrastructure for artificial intelligence workloads. The agreement strengthens cooperation between the two companies across the entire AI technology stack—from large-scale AI infrastructure…
-
Biogen shares Phase 1b findings for salanersen in spinal muscular atrophy
Biogen Inc. (NASDAQ:BIIB) unveiled results from a Phase 1b clinical study evaluating salanersen, an experimental antisense oligonucleotide therapy for spinal muscular atrophy (SMA), during the 2026 Muscular Dystrophy Association Clinical & Scientific Conference on Wednesday. The trial involved 24 children aged between six months and 12 years who continued to show suboptimal clinical outcomes after…
-
Campbell Soup shares fall after earnings miss and lowered outlook
Campbell Soup Company (NASDAQ:CPB) shares dropped more than 5% in premarket trading Wednesday after the company reported fiscal second-quarter 2026 results that came in below expectations and cut its full-year guidance. The food producer reported earnings per share of $0.51 for the quarter, missing analyst forecasts of $0.57. Revenue totaled $2.6 billion, slightly under the…
-
Kamada shares slip more than 2% after fourth-quarter earnings miss
Kamada Ltd. (NASDAQ:KMDA) reported fourth-quarter results on Wednesday that came in below analyst expectations. The company’s stock fell about 2.46% in pre-market trading following the release of the results. For the fourth quarter, Kamada posted adjusted earnings of $0.06 per share, missing the analyst consensus estimate of $0.10 by $0.04. Quarterly revenue totaled $44.68 million,…
-
Broadwind shares drop more than 6% after Q4 earnings miss despite revenue beat
Broadwind Inc. (NASDAQ:BWEN) reported fourth-quarter results on Wednesday that fell short of earnings expectations, even though revenue came in above analyst forecasts. The company’s shares declined about 6.64% in pre-market trading following the release of the results. Broadwind posted an adjusted loss of $0.04 per share for the fourth quarter, missing the analyst consensus estimate…
-
Sprinklr shares rise after fourth-quarter results top estimates
Sprinklr Inc. (NYSE:CXM) moved higher in premarket trading Wednesday after the company reported fourth-quarter results that came in ahead of analyst forecasts. The firm posted adjusted earnings of $0.13 per share, exceeding the consensus estimate of $0.09. Quarterly revenue reached $220.6 million, above the $215.51 million expected by analysts and up 9% from $202.5 million…
-
Serve Robotics shares jump after partnership with White Castle for robot deliveries
Serve Robotics Inc. (NASDAQ:SERV) surged about 12% on Wednesday after announcing a new partnership with White Castle to deliver food orders using autonomous robots through the Uber Eats service. Customers ordering White Castle meals within Serve’s delivery coverage area will now be able to receive their orders via the company’s autonomous sidewalk robots. The agreement…
-
Nike shares climb after Barclays upgrades stock to Overweight
Nike Inc. (NYSE:NKE) rose about 2% on Wednesday after Barclays upgraded the sportswear giant to Overweight from Equalweight and lifted its price target to $73 from $64. Barclays analyst Adrienne Yih said the upgrade reflects recent operational improvements, financial turning points and management’s disciplined execution. “While acknowledging ongoing risks, we believe the risk/reward profile has…
-
Acacia Research shares rise over 3% after Q4 earnings and revenue top estimates
Acacia Research Corporation (NASDAQ:ACTG) reported fourth-quarter results on Wednesday that exceeded analyst forecasts for both earnings and revenue. The company posted adjusted earnings of $0.03 per share for the quarter, compared with analysts’ expectations of a loss of $0.14 per share. Revenue came in at $50.1 million, beating the $38 million consensus estimate. Sales rose…